Current pharmacotherapies for advanced lung cancer with pre-existing interstitial lung disease : A literature review and future perspectives-Reference-Cited by-同舟云学术

Current pharmacotherapies for advanced lung cancer with pre-existing interstitial lung disease : A literature review and future perspectives

Published:2024 Issue:1.2 Volume:71 Page:9-22
ISSN:1343-1420
Container-title:The Journal of Medical Investigation
language:en
Short-container-title:J. Med. Invest.

Author:

Hanibuchi Masaki¹,Ogino Hirokazu²,Sato Seidai²,Nishioka Yasuhiko²

Affiliation:

1. Department of Community Medicine for Respirology, Hematology, and Metabolism, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan

2. Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan

Publisher

University of Tokushima Faculty of Medicine

Link

https://www.jstage.jst.go.jp/article/jmi/71/1.2/71_9/_pdf

Reference126 articles.

1. 1. Raghu G, Nyberg F, Morgan G : The epidemiology of interstitial lung disease and its association with lung cancer. Br J Cancer 91 : S3-S10, 2004

2. 2. Ogura T, Takigawa N, Tomii K, Kishi K, Inoue Y, Ichihara E, Homma S, Takahashi K, Akamatsu H, Ikeda S, Inase N, Iwasawa T, Ohe Y, Ohta H, Onishi H, Okamoto I, Ogawa K, Kasahara K, Karata H, Kishimoto T, Kitamura Y, Gemma A, Kenmotsu H, Sakashita H, Sakamoto S, Sekine K, Takiguchi Y, Tada Y, Toyooka S, Nakayama Y, Nishioka Y, Hagiwara K, Hanibuchi M, Fukuoka J, Minegishi Y, Yanagihara T, Yamamoto N, Yamamoto H, Gaga M, Fong KM, Powell CA, Kiura K ; DLD / TO Assemblies of JRS : Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia. Respir Investig 57 : 512-533, 2019

3. 3. Lederer DJ, Martinez FJ : Idiopathic pulmonary fibrosis. N Engl J Med 378 : 1811-1823, 2018

4. 4. Natsuizaka M, Chiba H, Kuronuma K, Otsuka M, Kudo K, Mori M, Bando M, Sugiyama Y, Takahashi H : Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am J Respir Crit Care Med 190 : 773-779, 2014

5. 5. Taniguchi H, Ebina M, Kondoh Y, Ogura T, Azuma A, Suga M, Taguchi Y, Takahashi H, Nakata K, Sato A, Takeuchi M, Raghu G, Kudoh S, Nukiwa T ; Pirfenidone Clinical Study Group in Japan : Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 35 : 821-829, 2010